Latest news
Heart attack: GLP-1 drug tirzepatide may cut risk by 33% - Medical News TodayMedical News Today · Mon, 10 Aug 2026 15:26:05 GMTTirzepatide lowers heart attack and cardiovascular event risk in adults with type 2 diabetes - News-MedicalNews-Medical · Mon, 10 Aug 2026 06:17:00 GMTTirzepatide Cuts MACE Risk in Diabetes With Heart Disease - Pharmacy TimesPharmacy Times · Sun, 09 Aug 2026 14:05:20 GMTMemorial doctor discusses benefits, risks of GLP-1 weight loss medications - WLBTWLBT · Sat, 08 Aug 2026 13:44:00 GMTAMA, Vaccine Integrity Project launch independent vaccine review; tirzepatide tied to lower diabetic eye disease risk; ACLM updates guidance of treatment, prevention of chronic disease – Morning Medical Update - Medical EconomicsMedical Economics · Sat, 08 Aug 2026 04:03:48 GMTHundreds of deaths linked to weight-loss drugs: report - keysnews.comkeysnews.com · Thu, 06 Aug 2026 18:34:50 GMTGLP-1 drug linked to heart benefits for high-risk patients - Medical XpressMedical Xpress · Wed, 05 Aug 2026 22:30:01 GMT